Doxycycline is a safe alternative to Hydroxychloroquine + Azithromycin to prevent clinical worsening and hospitalization in mild COVID-19 patients: An open label randomized clinical trial (DOXYCOV)

Eugene Sobngwi; Sylvain Zemsi; Magellan Guewo-Fokeng; Jean-Claude Katte; Charles Kounfack; Liliane Mfeukeu-Kuate; Armel Zemsi; Yves Wasnyo; Antoinette Assiga Ntsama; Arnaud Ndi-Manga; Joelle Sobngwi-Tambekou; William Ngatchou; Charlotte Moussi Omgba; Jean Claude Mbanya; Pierre Ongolo Zogo; Pierre Joseph Fouda

bioRxiv (2021) - Comments
doi: 10.1101/2021.07.25.21260838

Eugene Sobngwi, Sylvain Zemsi, Magellan Guewo-Fokeng, Jean-Claude Katte, Charles Kounfack, Liliane Mfeukeu-Kuate, Armel Zemsi, Yves Wasnyo, Antoinette Assiga Ntsama, Arnaud Ndi-Manga, Joelle Sobngwi-Tambekou, William Ngatchou, Charlotte Moussi Omgba, Jean Claude Mbanya, Pierre Ongolo Zogo, Pierre Joseph Fouda